A strategy for designing inhibitors of alpha-synuclein aggregation and toxicity as a novel treatment for Parkinson's disease and related disorders.

Source:http://linkedlifedata.com/resource/pubmed/id/15180968

Download in:

View as

General Info

PMID
15180968